| Trade Names: | |
| Synonyms: | |
| Status: | Approved (2000) |
| Entry Type: | Enzyme |
| Molecule Category: | UNKNOWN |
| ATC: | B01AD11 |
| UNII: | WGD229O42W |
| Action | Mechanism of Action | Reference |
|---|---|---|
| ACTIVATOR | Plasminogen activator | Other |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Myocardial Infarction | 4 | D009203 | ClinicalTrials |
| Thrombosis | 4 | D013927 | ClinicalTrials |
| ST Elevation Myocardial Infarction | 3 | D000072657 | ClinicalTrials |
| Pulmonary Embolism | 3 | D011655 | ClinicalTrials |
| Death, Sudden, Cardiac | 3 | D016757 | ClinicalTrials |
| Stroke | 3 | D020521 | ClinicalTrials |
| Retinal Artery Occlusion | 3 | D015356 | ClinicalTrials |
| Ischemic Stroke | 3 | D000083242 | ClinicalTrials |
| Cerebral Infarction | 2 | D002544 | ClinicalTrials |
| Brain Ischemia | 2 | D002545 | ClinicalTrials |
| Nervous System Diseases | 2 | D009422 | ClinicalTrials |
| Pleural Effusion | 2 | D010996 | ClinicalTrials |
| Respiratory Distress Syndrome | 1 | D012128 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 191588-94-0 |
| ChEMBL | CHEMBL2108791 |
| FDA SRS | WGD229O42W |